MedPath

Mindfulness Based Cognitive Therapy for Fear of Recurrence in Ovarian Cancer Survivors. (FROCS)

Not Applicable
Completed
Conditions
Fear of recurrence.
Ovarian Cancer
Cancer - Ovarian and primary peritoneal
Mental Health - Anxiety
Registration Number
ACTRN12615000213549
Lead Sponsor
Dr Paul Cohen
Brief Summary

Results not yet available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
20
Inclusion Criteria

Have a confirmed diagnosis of primary or recurrent epithelial ovarian carcinoma (any histopathological subtype and any stage of disease at diagnosis)
- Are being treated with curative intent
- Have completed all hospital-based adjuvant treatments
- Are disease-free
- Are fluent in English
- Are over 18 years of age

Exclusion Criteria

- Germ cell or stromal tumours
- Currently have severe major depression with suicidal ideation
- Are currently receiving psychological treatment
- Currently have active psychotic illness or psychiatric/cognitive condition.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fear of Ovarian Cancer Recurrence.<br>Fear of Cancer Recurrence is assessed using the 42-item FCRI, the most comprehensive multi-dimensional scale of FCR available, and suitable for patients with mixed cancer diagnoses. It has been found to be internally consistent (Chronbach’s a=0.75 to 0.91 across subscales) and stable over a two-week interval (query = 0.58 to 0.83 across subscales), and has a robust factor structure. The FCRI has convergent validity with other standardised measures of FCR and discriminant validity with QOL amongst a large sample (n = 600) of Canadian cancer patients with mixed tumours. Respondents rate the degree to which symptoms or issues affect them on a Likert scale ranging from 0 (‘not at all’ or ‘never’) to 4 (‘a great deal’ or ‘all the time’). Higher scores indicate higher FCR.[Immediately prior to the first MBCT group class, at the conclusion of the MBCT course and 6 months after completion of the MBCT intervention.]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath